Syndax Pharmaceuticals (SNDX) Other Operating Expenses (2024 - 2026)

Syndax Pharmaceuticals' Other Operating Expenses history runs 4 years deep, the most recent figure standing at $2.6 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 197.51% year-over-year to $2.6 million; the TTM figure through Mar 2026 stood at -$10.2 million (down 127.65% YoY), while the FY2025 annual figure was $1.3 million, up 419.43% from the prior year.
• Other Operating Expenses for Q1 2026 stood at $2.6 million, up from -$2.1 million in the prior quarter.
• The five-year high for Other Operating Expenses was $52.1 million in Q3 2024, with the low at -$11.8 million in Q2 2024.
• The 4-year median for Other Operating Expenses is -$2.1 million (2025), against an average of $4.5 million.
• The sharpest annual moves came in 2025 and 2026: Other Operating Expenses slumped 113.44% in 2025, then soared 197.51% in 2026.
• Syndax Pharmaceuticals' Other Operating Expenses stood at $13.7 million in 2022, then tumbled by 132.15% to -$4.4 million in 2024, then jumped by 52.6% to -$2.1 million in 2025, then surged by 225.8% to $2.6 million in 2026.
• Business Quant data shows SNDX's Other Operating Expenses at $2.6 million in Q1 2026, -$2.1 million in Q4 2025, and -$7.0 million in Q3 2025.